DJ Inovio Pharmaceuticals Inc. Stock Remains Steady Wednesday, Still Outperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ were unchanged Wednesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 0.56% to 18,607.93 and Dow Jones Industrial Average falling 0.22% to 42,141.54.
Inovio Pharmaceuticals Inc. closed $9.19 below its 52-week high ($14.75), which the company achieved on April 1st.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ rose 0.32% to $160.61, Statera Biopharma Inc. (STAB) fell 33.33% to $0.00, and Pfizer Inc. $(PFE)$ rose 0.21% to $28.52.
Trading volume (179,508) remained 119,045 below its 50-day average volume of 298,553.
Data source: Dow Jones Market Data, FactSet. Data compiled October 30, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
October 30, 2024 17:27 ET (21:27 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。